drugset / Trial / NCT04263350
A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to compare the amount of Atazanavir (ATV) and Cobicistat (COBI) in the bodies of healthy adult participants when taken as a combination formulation, and when ATV is administered as an oral powder at the same time as COBI administered as an oral tablet. The ATV/COBI combination formulation and ATV powder will be taken with food.
Timeline
- Start
- 2020-02-26
- Primary completion
- 2020-11-12
- Completion
- 2020-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atazanavir | Other / unclassified | — | Oral |
| Subject | Cobicistat | Small molecule | — | Oral |
Indications
No indication recorded.